Filing Details
- Accession Number:
- 0000899243-20-025693
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-18 16:05:20
- Reporting Period:
- 2020-09-16
- Accepted Time:
- 2020-09-18 16:05:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1743881 | Bridgebio Pharma Inc. | BBIO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1214133 | H Richard Scheller | C/O Bridgebio Pharma, Inc. 421 Kipling Street Palo Alto CA 94301 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-09-16 | 25,000 | $37.50 | 138,427 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2020.
Billionaire Hedge Funds
